Romosozumab to Improve Bone Mineral Density and Architecture in Chronic Spinal Cord Injury
ClinicalTrials.gov ID: NCT04232657
The purpose of this clinical trial is to evaluate the ability of two bone-active medications (romosozumab and denosumab) on osteoporosis after spinal cord injury. This study is currently closed for enrollment and no longer recruiting participants.
For more information, please click here.